Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

PLRX holding history

Pliant Therapeutics, Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PLRX overviewAll 13F holders of PLRXFull Q2 2026 holdings

Shares (Q2 2026)
772,126
Value
$880.2K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of PLRX by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026772,126$880.2K0.1%00.0%UnchangedHolders
Q1 2026772,126$972.9K0.1%−844,102−52.2%ReducedHolders
Q4 20251,616,228$1.97M0.1%+24,533+1.5%AddedHolders
Q3 20251,591,695$2.36M0.2%−40,882−2.5%ReducedHolders
Q2 20251,632,577$1.89M0.2%−420,982−20.5%ReducedHolders
Q1 20252,053,559$2.77M0.3%−841,919−29.1%ReducedHolders
Q4 20242,895,478$38.1M2.7%−302,013−9.4%ReducedHolders
Q3 20243,197,491$35.8M2.1%−12,100−0.4%ReducedHolders
Q2 20243,209,591$34.5M2.1%+112,371+3.6%AddedHolders
Q1 20243,097,220$46.1M1.7%+400,572+14.9%AddedHolders
Q4 20232,696,648$48.8M1.7%+18,549+0.7%AddedHolders
Q3 20232,678,099$46.4M2.2%00.0%UnchangedHolders
Q2 20232,678,099$48.5M1.9%−247,549−8.5%ReducedHolders
Q1 20232,925,648$77.8M3.4%−952,951−24.6%ReducedHolders
Q4 20223,878,599$75.0M3.1%−629,605−14.0%ReducedHolders
Q3 20224,508,204$94.2M3.7%+1,439,203+46.9%AddedHolders
Q2 20223,069,001$24.6M0.9%−11,800−0.4%ReducedHolders
Q1 20223,080,801$21.6M0.7%−2,700−0.1%ReducedHolders
Q4 20213,083,501$41.6M0.9%00.0%UnchangedHolders
Q3 20213,083,501$52.0M0.9%−72,900−2.3%ReducedHolders
Q2 20213,156,401$91.9M1.4%−50,792−1.6%ReducedHolders
Q1 20213,207,193$126.1M1.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.